Portfolio company
TripleMed
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This medical technology company develops injectable polymer solutions to treat and prevent aortic aneurysms for surgeons and hospitals.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Aortyx
This company develops bioresorbable endovascular patches and catheter delivery systems for surgeons to treat patients with aortic dissection and other vascular diseases.
TRiCares
This company develops a catheter-based tricuspid valve replacement system for patients suffering from tricuspid regurgitation.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
AorticLab
This company develops embolic protection devices and aortic valve treatment systems for healthcare professionals performing transcatheter cardiovascular procedures.
Tulyp Medical
This company develops autonomous pressure-guided perfusion systems to preserve tissue viability and maintain healthy blood flow for patients undergoing vascular surgical procedures.
CroíValve
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
OctoVascular
OctoVascular develops automated vessel connection technology for surgeons to perform minimally invasive coronary artery bypass surgery.
STENTiT
The company develops biodegradable endovascular implants that promote vascular tissue regeneration to treat patients suffering from cardiovascular diseases like peripheral artery disease.